{
    "relation": [
        [
            "Treatments",
            "insulin",
            "rapamycin"
        ],
        [
            "Referenced Treatments",
            "",
            "insulin"
        ],
        [
            "Manipulated Protein",
            "",
            ""
        ],
        [
            "Referenced Protein",
            "",
            ""
        ],
        [
            "Effect",
            "increase",
            "inhibit treatment-induced increase"
        ],
        [
            "Notes",
            "",
            ""
        ]
    ],
    "pageTitle": "Curated Information",
    "title": "",
    "url": "http://www.phosphosite.org/curatedInfoAction.do?record=11387250",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990112.92/warc/CC-MAIN-20150728002310-00252-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 642895563,
    "recordOffset": 642883280,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "\u00a0Potential in vivo enzymes for site:\u00a0 Upstream Regulation p70S6K (human) KINASE Enzyme Type \u00a0Enzymes shown to modify site in vitro:\u00a0 \u00a0Species studied:\u00a0 human, mouse \u00a0Cellular systems studied:\u00a0 cell lines \u00a0Relevant cell lines - cell types - tissues:\u00a0 293 (epithelial), 3T3-L1 (fibroblast), C2C12 (myoblast), HepG2 (hepatic) \u00a0Disease tissue studied:\u00a0 liver cancer \u00a0Methods used to characterize site in vivo:\u00a0 mass spectrometry, mutation of modification site, phospho-antibody, western blotting Characterization RICTOR\u00a0(human): T1135\u2011p, RICTOR\u00a0iso3\u00a0(human): T1135\u2011p, RICTOR\u00a0iso4\u00a0(human): \u2011, RICTOR\u00a0(mouse): T1135\u2011p, RICTOR\u00a0(rat): T1120\u2011p Orthologous residues \u25b2 T1135-p\u00a0-\u00a0RICTOR (human)",
    "textAfterTable": "Manipulated Protein Referenced Protein Effect Notes insulin increase rapamycin insulin inhibit treatment-induced increase Downstream Regulation \u00a0Effect of modification (function):\u00a0 molecular association, regulation, phosphorylation \u00a0Modification regulates interactions with:\u00a0 Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays 14-3-3 beta (human) Induces pull-down assay, co-immunoprecipitation \u00a0Comments:\u00a0 cells expressing Rictor T1135A exhibit an increase in insulin-stimulated Akt-S473 and TSC2-T1462 phosphorylation S1138-p\u00a0-\u00a0RICTOR (human)",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}